肺大细胞癌蛋白标志物的表达及临床意义
The Expression and Clinical Significance in of Protein Markers Pulmonary Large cell Carcinoma
-
摘要: 目的 探讨肺大细胞癌蛋白标志物的表达及临床意义.方法 检测肺大细胞癌蛋白标志物的表达并分型, 分析各种蛋白标志物敏感性和特异性, 统计各型肺大细胞癌淋巴结转移率及EGFR突变率的差异.结果肺大细胞癌可不同程度表达CK7、TTF1、Napsin A、CK5/6、p63、SOX2、p40、Cg A和Syn9种蛋白标志物, 并根据各种蛋白标志物的表达情况将肺大细胞癌分为腺癌型、鳞癌型和干细胞型;CK7、TTF1、Napsin A对肺大细胞癌腺癌型的敏感性分别为100%、63.33%、76.67%, 特异性分别为62.5%、100%、100%.CK5/6、p63、SOX2、p40对肺大细胞癌鳞癌型的敏感性分别为100%、87.5%、87.5%、87.5%, 特异性分别为73.33%、83.33%、96.67%、96.67%;各型肺大细胞癌淋巴结转移率差异无统计学意义 (P>0.05) ;各型肺大细胞癌EGFR突变率差异有统计学意义 (P<0.05) , 干细胞型>腺癌型>鳞癌型.结论 检测肺大细胞癌蛋白标志物并对其分型是有必要的, 其有利于为临床判断预后及制定合理、有效的个体化治疗方案;腺癌型蛋白标志物的优劣顺序为Napsin A>TTF1>CK7, 鳞癌型蛋白标志物的优劣顺序为SOX2=p40>p63>CK5/6.Abstract: Objective To investigate the expression and clinical significance in of protein markers pulmonary large cell carcinoma (PLCC) .Methods We detected the expression of protein markers of PLCC, and classified the PLCC.We also evaluated the sensibility and specificity of the protein markser.Results The PLCC expressed different protein markers:CK7, TTF1, Napsin A, CK5/6, p63, SOX2, p40, CgA and Syn.The sensibility and specificity of CK7, TTF1, Napsin A was 100%, 63.33%, 76.67% and 62.5%, 100%, 100%.The sensibility and specificity of CK5/6, p63, SOX2, p40 was 100%, 87.5%, 87.5%, 87.5% and 73.33%, 83.33%, 96.67%, 96.67%.The difference of lymph node metastasis rate of every type of pulmonary large cell carcinoma had no statistical significance (P>0.05) , the difference of mutation rate of EGFR of every type of pulmonary large cell carcinoma was statistically significant ( P <0.05) , stem carcinoma>adenocarcinoma>squamous carcinoma.Conclusion It is necessary to detect protein markers of pulmonary large cell carcinoma and their classification.It is helpful to clinical prognosis and to establish reasonable and effective individualized treatment.The sequence number of the sensibility and specificity to adenocarcinoma is Napsin A>TTF1>CK7, to squamous carcinoma is SOX2=p40>p63>CK5/6.
-
Key words:
- Large cell carcinoma /
- Protein marker /
- Classification /
- Sensibility /
- Specificity /
- Individualized treatment
-
[1] [1]TRAVIS W D, BRAMBILLA E, BURKE A P, et al.Large cell Carcinoma.WHO Classification of Tumours of the Lung, Pleura, Thymus and Heart[M].Lyon, 2015:80-86.[1]TRAVIS W D, BRAMBILLA E, BURKE A P, et al.Large cell Carcinoma.WHO Classification of Tumours of the Lung, Pleura, Thymus and Heart[M].Lyon, 2015:80-86. [2]孟宇宏, 张建中主译.肺、胸膜及心脏肿瘤病理学和遗传学[M].北京:人民卫生出版社, 2006:45.[2]孟宇宏, 张建中主译.肺、胸膜及心脏肿瘤病理学和遗传学[M].北京:人民卫生出版社, 2006:45. [3]徐启明, 周乃康, 刘颖, 等.58例肺大细胞癌的诊断和外科治疗[J].中国肿瘤临床, 2008, 35 (1) :15-17.[3]徐启明, 周乃康, 刘颖, 等.58例肺大细胞癌的诊断和外科治疗[J].中国肿瘤临床, 2008, 35 (1) :15-17. [4]李军华, 魏海龙, 张志东.12例肺大细胞癌的诊断与治疗体会[J].海南医学, 2010, 21 (21) :72-76.[4]李军华, 魏海龙, 张志东.12例肺大细胞癌的诊断与治疗体会[J].海南医学, 2010, 21 (21) :72-76. [5] [5]NEKULOVA M, HOLCAKOVA J, COATES P, et al.The role of p63 in cancer, stem cells and cancer stem cells[J].Cell Mol Biol Lett, 2011, 16 (2) :96-327.[5]NEKULOVA M, HOLCAKOVA J, COATES P, et al.The role of p63 in cancer, stem cells and cancer stem cells[J].Cell Mol Biol Lett, 2011, 16 (2) :96-327. [6] [6]RIGHI L, GRAZIANO P, FORNARI A.Immunohistochemical subtyping of nonsmall cell lung cancer not otherwise specified in fine-needle aspiration cytology:A retrospective study of 103 cases with surgical correlation[J].Cancer, 2011, 117 (15) :3416-3423.[6]RIGHI L, GRAZIANO P, FORNARI A.Immunohistochemical subtyping of nonsmall cell lung cancer not otherwise specified in fine-needle aspiration cytology:A retrospective study of 103 cases with surgical correlation[J].Cancer, 2011, 117 (15) :3416-3423. [7] [7]REKHTMAN N, ANG D C, SIMA C S, et al.Immunohistochemical algorithm for differentiation of lung adenocarcinoma and squamous cell carcinoma based on large series of whole-tissue sectons with validation in small specimens[J].Mod Pathol, 2011, 24 (10) :1348-1359.[7]REKHTMAN N, ANG D C, SIMA C S, et al.Immunohistochemical algorithm for differentiation of lung adenocarcinoma and squamous cell carcinoma based on large series of whole-tissue sectons with validation in small specimens[J].Mod Pathol, 2011, 24 (10) :1348-1359. [8] [8]YOSHIDA A, TSUTA K, NAKAMURA H.Comprehensive histologic analysis of ALK-rearrangde lung carcinomas[J].Am J Surg Pathol, 2011, 35 (8) :1226-1234.[8]YOSHIDA A, TSUTA K, NAKAMURA H.Comprehensive histologic analysis of ALK-rearrangde lung carcinomas[J].Am J Surg Pathol, 2011, 35 (8) :1226-1234.
点击查看大图
计量
- 文章访问数: 2192
- HTML全文浏览量: 858
- PDF下载量: 88
- 被引次数: 0